Planegg/Martinsried (19.02.2024) Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will present at the 7th CAR-TCR Summit Europe taking place February 27-29, 2024, in London as well as at the East-West Biopharma Summit to be held March 4-6, 2024, in Singapore. 7th CAR-TCR Summit Europe 2024https://cartcr-europe.com/ PresentationDate: February 28, 2024, 5:30 pm local timeLocation: London, UKPresenter: Prof. Dr. Dolores Schendel, CSOPresentation: Developing effective methods to ...
[ more ]
